Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

EPA:CLA - Euronext Paris - Matif - FR0013426004 - Common Stock - Currency: EUR

2.46  -0.03 (-1.2%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLA. CLA was compared to 99 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
CLA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
CLA had a positive operating cash flow in each of the past 5 years.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

The Return On Assets of CLA (-4.90%) is worse than 64.65% of its industry peers.
CLA has a better Return On Invested Capital (23.05%) than 94.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLA is significantly above the industry average of 11.50%.
The 3 year average ROIC (17.26%) for CLA is below the current ROIC(23.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROIC 23.05%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

CLA has a Operating Margin of 7.46%. This is comparable to the rest of the industry: CLA outperforms 58.59% of its industry peers.
CLA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 28.55%, CLA is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.46%
PM (TTM) N/A
GM 28.55%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLA is creating value.
The number of shares outstanding for CLA has been increased compared to 1 year ago.
CLA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that CLA is in the distress zone and has some risk of bankruptcy.
CLA's Altman-Z score of 1.49 is in line compared to the rest of the industry. CLA outperforms 40.40% of its industry peers.
The Debt to FCF ratio of CLA is 4.39, which is a neutral value as it means it would take CLA, 4.39 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.39, CLA perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Altman-Z 1.49
ROIC/WACC3.09
WACC7.45%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.75 indicates that CLA may have some problems paying its short term obligations.
With a Current ratio value of 0.75, CLA is not doing good in the industry: 79.80% of the companies in the same industry are doing better.
CLA has a Quick Ratio of 0.75. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Quick ratio (0.61) than 82.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.61
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CLA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.00%.
Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -2.23% in the last year.
Measured over the past years, CLA shows a quite strong growth in Revenue. The Revenue has been growing by 13.58% on average per year.
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.27%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%

3.2 Future

Based on estimates for the next years, CLA will show a very strong growth in Earnings Per Share. The EPS will grow by 43.35% on average per year.
The Revenue is expected to grow by 3.30% on average over the next years.
EPS Next Y106.06%
EPS Next 2Y51.76%
EPS Next 3Y43.35%
EPS Next 5YN/A
Revenue Next Year0.45%
Revenue Next 2Y3.22%
Revenue Next 3Y3.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.60, the valuation of CLA can be described as reasonable.
Based on the Price/Forward Earnings ratio, CLA is valued cheaper than 95.96% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CLA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.6
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaper than 91.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.08
EV/EBITDA 5.2
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 43.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.76%
EPS Next 3Y43.35%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (3/7/2025, 7:00:00 PM)

2.46

-0.03 (-1.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13
Earnings (Next)03-27 2025-03-27
Inst Owners19.42%
Inst Owner ChangeN/A
Ins Owners16.66%
Ins Owner ChangeN/A
Market Cap140.74M
Analysts47.5
Price Target1.94 (-21.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-41.84%
PT rev (3m)-41.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.56%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.6
P/S 0.28
P/FCF 4.08
P/OCF 3.55
P/B N/A
P/tB N/A
EV/EBITDA 5.2
EPS(TTM)-0.22
EYN/A
EPS(NY)0.29
Fwd EY11.63%
FCF(TTM)0.6
FCFY24.51%
OCF(TTM)0.69
OCFY28.21%
SpS8.66
BVpS-0.17
TBVpS-2.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.9%
ROE N/A
ROCE 31.36%
ROIC 23.05%
ROICexc 33.57%
ROICexgc N/A
OM 7.46%
PM (TTM) N/A
GM 28.55%
FCFM 6.96%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score5
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.39
Debt/EBITDA 2.49
Cap/Depr 42.98%
Cap/Sales 1.05%
Interest Coverage 250
Cash Conversion 80.86%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.61
Altman-Z 1.49
F-Score5
WACC7.45%
ROIC/WACC3.09
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.27%
EPS Next Y106.06%
EPS Next 2Y51.76%
EPS Next 3Y43.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%1.25%
Revenue Next Year0.45%
Revenue Next 2Y3.22%
Revenue Next 3Y3.3%
Revenue Next 5YN/A
EBIT growth 1Y42.31%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year47.17%
EBIT Next 3Y21.95%
EBIT Next 5YN/A
FCF growth 1Y2256.25%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y326.88%
OCF growth 3Y28.52%
OCF growth 5Y40.7%